v3.26.1
Note 1 - Business and Organization (Details Textual)
2 Months Ended 12 Months Ended
Mar. 04, 2026
USD ($)
Dec. 31, 2025
USD ($)
Dec. 31, 2024
USD ($)
Sep. 30, 2017
Revenue from Contract with Customer, Including Assessed Tax   $ 7,765,000 $ 17,779,000  
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest   (15,189,000) (4,347,000)  
Cash Provided by (Used in) Operating Activity, Discontinued Operation   (8,297,000)    
Working Capital (Deficit)   51,000    
Assets, Current   5,114,000 7,137,000  
Cash and Cash Equivalent   3,883,000 3,548,000  
Long-Term Debt   2,079,000    
Stock Issued During Period, Value, New Issues   2,027,000 594,000  
Proceeds from Issuance of Common Stock   $ 2,027,000 594,000  
Number of Wholly-Owned Subsidiaries   5    
BioLargo Energy Technologies, Inc (BETI) [Member]        
Subsidiary, Ownership Percentage, Parent   95.00%    
Clyra Medical Technologies [Member]        
Subsidiary, Ownership Percentage, Parent   48.00%    
BioLargo Engineering, Science & Technologies, LLC [Member]        
Subsidiary, Ownership Percentage, Parent   70.00%   100.00%
Clyra Medical [Member]        
Proceeds from Issuance or Sale of Equity   $ 445,000    
Subsequent Event [Member] | Unsecured Debt [Member] | Clyra Medical [Member]        
Proceeds from Issuance of Debt $ 1,705,000      
Debt Instrument, Term (Year) 3 years      
Lincoln Park Capital Fund, LLC [Member]        
Stock Issued During Period, Value, New Issues   2,122,000    
Proceeds from Issuance of Common Stock   2,122,000 260,000  
Lincoln Park Capital Fund, LLC [Member] | Subsequent Event [Member]        
Proceeds from Issuance of Common Stock $ 170,704      
Accredited Investors [Member]        
Proceeds from Issuance or Sale of Equity   215,000    
Proceeds from Issuance of Common Stock   155,000 334,000  
Clyra Medical [Member] | Common Stock [Member]        
Proceeds from Issuance or Sale of Equity   2,339,000    
Clyra Medical [Member] | Series B Preferred Stock [Member]        
Proceeds from Issuance or Sale of Equity   2,145,000    
BioLargo Energy Technologies, Inc (BETI) [Member] | Common Stock [Member]        
Proceeds from Issuance or Sale of Equity   425,000    
Partially Owned Subsidiary [Member]        
Long-Term Debt   1,814,000    
Long-Term Debt, Current Maturities   1,395,000 486,000  
BioLargo Energy Technologies, Inc (BETI) [Member]        
Proceeds from Issuance of Common Stock   $ 425,000 $ 50,000  
BioLargo Energy Technologies, Inc (BETI) [Member] | Subsequent Event [Member]        
Proceeds from Issuance or Sale of Equity $ 462,000